Hepatocyte growth factor and basic fibroblast growth factor regulate atrial fibrosis in patients with atrial fibrillation and rheumatic heart disease via the mitogen-activated protein kinase signaling pathway

Experimental and Therapeutic Medicine

Volumn 6, Issue 5, 2013, Pages 1121-1126

  Li, Mingjiang ^a   Yi, Xin ^a   Ma, Lele ^a   Zhou, Yanli ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Atrial fibrosis; Basic fibroblast growth factor; Hepatocyte growth factor; Mitogen activated protein kinase signaling pathway; Rheumatic heart disease

Indexed keywords

FIBROBLAST GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; SCATTER FACTOR; STRESS ACTIVATED PROTEIN KINASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART ATRIUM MUSCLE; HEART MUSCLE; HEART MUSCLE FIBROSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; MALE; PROTEIN PHOSPHORYLATION; RHEUMATIC HEART DISEASE; WESTERN BLOTTING;

EID: 84884789079     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1274     Document Type: Article

References (38)

1. Cao X, Wang S, Jiang L, Liu L, Huang H and Lu Z: Embolic events in 93 elderly Chinese patients with atrial fibrillation. Chin Med J (Engl) 113: 320-323, 2000.
2. Man J and Marchlinski FE: Atrial fibrillation ablation and heart failure. Curr Cardiol Rep 14: 571-576, 2012.
3. Ollivier R, Donal E, Veillard D, Pavin D, Hamonic S, Daubert JC and Mabo P: Early and late cardiac ventricular reverse remodeling after catheter ablation for lone paroxysmal atrial fibrillation. Ann Cardiol Angeiol (Paris) 60: 1-8, 2011.
4. Efremidis M, Sideris A, Xydonas S, Letsas KP, Alexanian IP, Manolatos D, Mihas CC, Filippatos GS and Kardaras F: Ablation of atrial fibrillation in patients with heart failure: reversal of atrial and ventricular remodelling. Hellenic J Cardiol 49: 19-25, 2008.
5. Olasinska-Wisniewska A, Mularek-Kubzdela T, Grajek S, Marszalek A, Sarnowski W, Jemielity M, Seniuk W, Lesiak M, Prech M and Podzerek T: Impact of atrial remodeling on heart rhythm after radiofrequency ablation and mitral valve operations. Ann Thorac Surg 93: 1449-1455, 2012.
6. de Oliveira IM, Oliveira BD, Scanavacca MI and Gutierrez PS: Fibrosis, myocardial crossings, disconnections, abrupt turns, and epicardial reflections: do they play an actual role in human permanent atrial fibrillation? A controlled necropsy study. Cardiovasc Pathol 22: 65-69, 2013.
7. Platonov PG, Mitrofanova LB, Orshanskaya V and Ho SY: Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age. J Am Coll Cardiol 58: 2225-2232, 2011.
8. Kim SJ, Choisy SC, Barman P, Zhang H, Hancox JC, Jones SA and James AF: Atrial remodeling and the substrate for atrial fibrillation in rat hearts with elevated afterload. Circ Arrhythm Electrophysiol 4: 761-769, 2011.
9. Cha TJ, Ehrlich JR, Zhang L, Shi YF, Tardif JC, Leung TK and Nattel S: Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure. Circulation 109: 412-418, 2004.
10. Hong CS, Cho MC, Kwak YG, Song CH, Lee YH, Lim JS, Kwon YK, Chae SW and Kim DH: Cardiac remodeling and atrial fibrillation in transgenic mice overexpressing junctin. FASEB J 16: 1310-1312, 2002.
11. John B, Stiles MK, Kuklik P, et al: Electrical remodelling of the left and right atria due to rheumatic mitral stenosis. Eur Heart J 29: 2234-2243, 2008.
12. de Groot NM, Zeppenfeld K, Wijffels MC, Chan WK, Blom NA, Van der Wall EE and Schalij MJ: Ablation of focal atrial arrhythmia in patients with congenital heart defects after surgery: role of circumscribed areas with heterogeneous conduction. Heart Rhythm 3: 526-535, 2006.
13. Ishikawa H, Jo JI and Tabata Y: Liver anti-fibrosis therapy with mesenchymal stem cells secreting hepatocyte growth factor. J Biomater Sci Polym Ed 23: 2259-2272, 2012.
14. Okunishi K, Dohi M, Nakagome K, Tanaka R, Mizuno S, Matsumoto K, Miyazaki J, Nakamura T and Yamamoto K: A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J Immunol 175: 4745-4753, 2005.
15. Iwata K, Sawa Y, Kitagawa-Sakakida S, Kawaguchi N, Matsuura N, Nakamura T and Matsuda H: Gene transfection of hepatocyte growth factor attenuates the progression of cardiac remodeling in the hypertrophied heart. J Thorac Cardiovasc Surg 130: 719-725, 2005.
16. Cecchi F, Rabe DC and Bottaro DP: Targeting the HGF/Met signaling pathway in cancer therapy. Expert Opin Ther Targets 16: 553-572, 2012.
17. Trusolino L, Bertotti A and Comoglio PM: MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol 11: 834-848, 2010.
18. Faletto DL, Kaplan DR, Halverson DO, Rosen EM and Vande Woude GF: Signal transduction in c-met mediated motogenesis. EXS 65: 107-130, 1993.
19. Zhang YW and Vande Woude GF: HGF/SF-met signaling in the control of branching morphogenesis and invasion. J Cell Biochem 88: 408-417, 2003.
20. Ornitz DM: FGFs, heparan sulfate and FGFRs: complex interactions essential for development. Bioessays 22: 108-112, 2000.
21. Tan AY and Zimetbaum P: Atrial fibrillation and atrial fibrosis. J Cardiovasc Pharmacol 57: 625-629, 2011.
22. Xing XQ, Xu J, Su H and Lu YW: Association between myocardial connexin 40 and 45 expression and myocardial fibrosis in the rapid atrial pacing canine model. Zhonghua Xin Xue Guan Bing Za Zhi 39: 176-180, 2011 (In Chinese).
23. Chen YQ, Wang L, Su X, Tao L and Chen XF: Calpain-I, calpastatin, caspase-3 and apoptosis in the human left atrium in rheumatic atrial fibrillation. Zhonghua Xin Xue Guan Bing Za Zhi 34: 303-307, 2006 (In Chinese).
24. Flamme I, Schulze-Osthoff K and Jacob HJ: Mitogenic activity of chicken chorioallantoic fluid is temporally correlated to vascular growth in the chorioallantoic membrane and related to fibroblast growth factors. Development 111: 683-690, 1991.
25. Toledo RN, Borin A, Cruz OL, Ho PL, Testa JR and Fukuda Y: The action of topical basic fibroblast growth factor in facial nerve regeneration. Otol Neurotol 31: 498-505, 2010.
26. Abe M, Yokoyama Y and Ishikawa O: A possible mechanism of basic fibroblast growth factor-promoted scarless wound healing: the induction of myofibroblast apoptosis. Eur J Dermatol 22: 46-53, 2012.
27. Felix AS, Edwards RP, Stone RA, Chivukula M, Parwani AV, Bowser R, Linkov F and Weissfeld JL: Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patients. Br J Cancer 106: 2004-2009, 2012.
28. Virag JA, Rolle ML, Reece J, Hardouin S, Feigl EO and Murry CE: Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function. Am J Pathol 171: 1431-1440, 2007.
29. Taniyama Y, Morishita R, Aoki M, Hiraoka K, Yamasaki K, Hashiya N, Matsumoto K, Nakamura T, Kaneda Y and Ogihara T: Angiogenesis and antifibrotic action by hepatocyte growth factor in cardiomyopathy. Hypertension 40: 47-53, 2002.
30. Inoue T, Okada H, Kobayashi T, Watanabe Y, Kanno Y, Kopp JB, Nishida T, Takigawa M, Ueno M, Nakamura T and Suzuki H: Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice. FASEB J 17: 268-270, 2003.
31. Jun EJ, Kim HS and Kim YH: Role of HGF/c-Met in serum-starved ARPE-19 cells. Korean J Ophthalmol 21: 244-250, 2007.
32. Gu J, Liu X, Wang QX, Tan HW, Guo M, Jiang WF and Zhou L: Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts. Exp Cell Res 318: 2105-2115, 2012.
33. Ambrosino C, Iwata T, Scafoglio C, Mallardo M, Klein R and Nebreda AR: TEF-1 and C/EBPbeta are major p38alpha MAPK-regulated transcription factors in proliferating cardiomyocytes. Biochem J 396: 163-172, 2006.
34. Nagai Y, Miyata K, Sun GP, Rahman M, Kimura S, Miyatake A, Kiyomoto H, Kohno M, Abe Y, Yoshizumi M and Nishiyama A: Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts. Hypertension 46: 1039-1045, 2005.
35. Lu Z, Ding L, Hong H, Hoggard J, Lu Q and Chen YH: Claudin-7 inhibits human lung cancer cell migration and invasion through ERK/MAPK signaling pathway. Exp Cell Res 317: 1935-1946, 2011.
36. Cohen M, Marchand-Adam S, Lecon-Malas V, Marchal-Somme J, Boutten A, Durand G, Crestani B and Dehoux M: HGF synthesis in human lung fibroblasts is regulated by oncostatin M. Am J Physiol Lung Cell Mol Physiol 290: L1097-L1103, 2006.
37. Yang H, Xia Y, Lu SQ, Soong TW and Feng ZW: Basic fibroblast growth factor-induced neuronal differentiation of mouse bone marrow stromal cells requires FGFR-1, MAPK/ERK, and transcription factor AP-1. J Biol Chem 283: 5287-5295, 2008.
38. Muddasani P, Norman JC, Ellman M, van Wijnen AJ and Im HJ: Basic fibroblast growth factor activates the MAPK and NFkappaB pathways that converge on Elk-1 to control production of matrix metalloproteinase-13 by human adult articular chondrocytes. J Biol Chem 282: 3 1409-31421, 2007.